Navigation Links
Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers

government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2006, as amended, and its Form 10-Q for the period ended March 31, 2007. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2007 Poniard Pharmaceuticals, Inc. All Rights Reserved. Poniard and Poniard Pharmaceuticals are trademarks of Poniard Pharmaceuticals, Inc.

Taxotere(R) and Eloxatin(R) are trademarks or registered trademarks of their respective companies.

CONTACT: Julie Rathbun of Poniard Pharmaceuticals, +1-206-286-2517, jrathbun@poniard.com

Web site: http://www.poniard.com/

Ticker Symbol: (NASDAQ-NMS:PARD)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies

Post Your Comments:
(Date:11/19/2009)...re/ -- In response to an ever-increasing number of...s, Operation Pangea II, involving 24 countries, wa...anization,s International Medical Products Anti-Co...angers of buying medicines online. ,, The week ...ests and the seizure of thousands of potentially h...
(Date:11/19/2009)...e/ -- Riverain Medical announced today that the co...ical imaging distributor Christie Group to offer S...ray CAD. The exclusive agreement will bring Dayton...nadian market through Christie Group,s established...ced Chest Imaging increases the clarity of digital...
(Date:11/19/2009)...net Week of Action ,, SILVER SPRING, Md., Nov....rug Administration today completed a coordinated, ...tional Internet Week of Action (IIWA), intended to...,, (Logo: http://www.newscom.com/cgi-bin/prnh/...A,s Office of Criminal Investigations (OCI), in co...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Leukemia Lymphoma Society Pleased to Announce Partnership in Southern Ohio with Eisen Marketing Group 52076 1Leukemia Lymphoma Society Pleased to Announce Partnership in Southern Ohio with Eisen Marketing Group 52076 2Emerging Woman Business Owner of the Year Winner Offers 5 Tips to New Women Business Owners 52074 1Emerging Woman Business Owner of the Year Winner Offers 5 Tips to New Women Business Owners 52074 2Big Pharma to Big Biopharma 3A Frost 26 Sullivan Examines the Latest M 26A Trends and Opportunities 13082 1Big Pharma to Big Biopharma 3A Frost 26 Sullivan Examines the Latest M 26A Trends and Opportunities 13082 2
...icantly increase the risk of the most common form ...researchers at Massachusetts General,Hospital and ...r 7th issue,of American Journal of Human Genetics....e Project" (AGP) established three years ago to id... risk factors, may lead to more,aggressive therape...
...presented at,International CHEST Conference, PHIL... trial demonstrate that Perforomist(TM) (formotero...t provided prolonged bronchodilation,and increased...opium by,metered-dose inhaler (MDI). These data we...the annual scientific assembly of the American Col...
Other Medicine Technology:Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 2Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 3Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 2Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 3Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 4Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 5Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI 6
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Fir...today that a Special Meeting of Shareholders will ...of the Meeting is to consider approval of two spec...o approve and authorize the sale of all or substan... on the terms provided for in the asset purchase a...
(Date:11/20/2009)..., , QUINCY, Mass., Nov. 20 ... Supermarket Company removed from sale Shedd,s Cou...oli Rice and Shedd,s Country Crock ® Side Dis...sulfite allergen. ,, The following code dates ...k ® Side Dishes DELUXE Cheddar Broccoli Rice ...
(Date:11/20/2009)..., , CHICAGO, Nov. 20 /PRNewswire-USNewswire...sked the U.S. Food and Drug Administration (FDA) t...whitening chemicals. ,, Citing concern about t...inistered without the benefit of professional cons...ion said that the application of chemically based ...
(Date:11/20/2009)..., , WINSTON-SALEM, N.C., Nov. 20 /PRNewswir...t he is on a mission to redefine what it means to ...essional counselor with a specialty in family coun...t Wake Forest University, Gladding says research s...n leads to sadness and even depression during the ...
(Date:11/20/2009)... An editorial published online November 20 in the...ses the exaggerated fears and hopes that often app...rial provides guidance for both the media and jour...hwartz, M.D., M.S., and Steven Woloshin, M.D., M.S...tmouth Institute for Health Policy and Clinical Pr...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...is drugs causing jaw problems have you wondering: ...at there have been reports of partial death of a j...ications, but the risk is very small, according to...ecome brittle and to fracture — are high. More tha...
...vered that mutations in a gene known as SOS1 accou...n childhood genetic //disorder which occurs in one...y short stature, facial abnormalities, and learnin... for Genetics and Genomics (HPCGG) and Beth Israel...
...more reason why teenage years are perceived as 'tu...the Pandora's Box has opened. //Such teens are pro... their no'vice' contemporaries, a recent insight i...th of data from a 2004 addition survey. The survey...
... that is home to one-third of Canadians. The healt... endangering health of children in Ontario.// Chil...osed to high doses of radiation. Children were exp... Opposition leaders in the province have criticiz...
...ll now help detection of Neurological disorders in...ng any of them//. Melbourne researchers have ...ious smells such as coffee, whisky, roses and blea...iatry Clinic, Christos Pantelis said, "The test ha...
...me that is known to have healing properties. It wa...ism and the amount of telomerase expressed were// ...elomerase is also known to increase the rate of ca...imals express telomerase while others, like humans...
Other Medicine News:Health News:Study Uncovers Mutation Responsible for Noonan Syndrome 2Health News:Detection of Neurological Disorder is Just a Sniff Away!! 2Health News:Telomerase Expression Linked To Body Mass 2Health News:Telomerase Expression Linked To Body Mass 3
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: